Dr. Edgardo Santos

  • MD
  • Medical Oncologist
  • Spoken languages English


Career Positions

Current position(s)

  • Florida Precision Oncology - Medical Oncologist, Aventura, FL

Past position(s)

  • Lynn Cancer Institute - Medical Director of Cancer Research, Boca Raton, FL



  • University of Panama School of Medicine, MD, Medicine, Panama, Panama


  • Jackson Memorial Medical Center, MD, Internal Medicine, Miami, FL


  • University of Miami/Sylvester Comprehensive Cancer Center, Hematology/Medical Oncology, Miami, FL


Awards and honors

  • The Global Directory of Who’s WhoSpirit Award of the American Cancer Society

Clinical studies

Primary Objective • To assess whether ALK kinase domain mutations (G1202/C1156Y /I1171/L1196/ V1180/ F1174/ compound mutation) associated with drug resistance are prognostic for objective response to subsequent ALK inhibitor therapy. • To assess whether subsequent pemetrexed based chemotherapy improves objective response comparing to ALK inhibitor therapy for no ALK mutation patients • To evaluate objective responses of patients with specific genetic alterations (ALKL1198F/MET double mutation or high-level MET gene amplification) treated with crizotinib.

View Study